Neusoft Holds the Top Market Share of Medical Imaging Information System in China

September 19, 2023 02:30 PM IST | By Cision
 Neusoft Holds the Top Market Share of Medical Imaging Information System in China
Image source: Kalkine Media

SHENYANG, China, Sept. 19, 2023 /PRNewswire/ -- Recently, IDC released the report "China's Medical Imaging Information System Market Share in 2022", in which Neusoft Corporation (Neusoft, SSE:600718) held the top market share in this sector due to its profound understanding of the market, continuous technological innovation, and robust service capabilities.

For years, Neusoft has been actively engaged in the medical imaging information system sector, and providing higher quality, smarter, and more accessible medical environment for doctors and patients. With PACS/RIS product capabilities as the core, Neusoft has further developed the smart medical imaging solutions. By adhering to standard examination processes within medical institutions, Neusoft aims to enhance patient satisfaction, assist doctors in accurate diagnosis, and improve hospital management, thus contributing to the overall information-based development of hospitals' imaging business.

Neusoft's PACS/RIS system complies with DICOM, HL7 standards and IHE specifications. It leverages the emerging technologies such as IoT, artificial intelligence and big data to provide services to various departments within medical institutions, to meet the needs of hospital administrators, doctors and patients.

 


Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media Limited, Company No. 12643132 (Kalkine Media, we or us) and is available for personal and non-commercial use only. Kalkine Media is an appointed representative of Kalkine Limited, who is authorized and regulated by the FCA (FRN: 579414). The non-personalised advice given by Kalkine Media through its Content does not in any way endorse or recommend individuals, investment products or services suitable for your personal financial situation. You should discuss your portfolios and the risk tolerance level appropriate for your personal financial situation, with a qualified financial planner and/or adviser. No liability is accepted by Kalkine Media or Kalkine Limited and/or any of its employees/officers, for any investment loss, or any other loss or detriment experienced by you for any investment decision, whether consequent to, or in any way related to this Content, the provision of which is a regulated activity. Kalkine Media does not intend to exclude any liability which is not permitted to be excluded under applicable law or regulation. Some of the Content on this website may be sponsored/non-sponsored, as applicable. However, on the date of publication of any such Content, none of the employees and/or associates of Kalkine Media hold positions in any of the stocks covered by Kalkine Media through its Content. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music/video that may be used in the Content are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures displayed/music or video used in the Content unless stated otherwise. The images/music/video that may be used in the Content are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source wherever it was indicated or was found to be necessary.

Top Penny Picks under 20 Cents to Fit Your Pocket! Get Exclusive Report on Penny Stocks For FREE Now.

Sponsored Articles


We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.